BioLineRx Announces Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting
BioLineRx Reports Year-End 2020 Financial Results and Provides Corporate Update